z-logo
open-access-imgOpen Access
The Multitarget Ligand 3-Iodothyronamine Modulates β-Adrenergic Receptor 2 Signaling
Author(s) -
Juliane Dinter,
Noushafarin Khajavi,
Jessica Mühlhaus,
Carolin Leonie Wienchol,
Maxi Cöster,
Thomas Hermsdorf,
Claudia Stäubert,
Josef Köhrle,
Torsten Schöneberg,
Gunnar Kleinau,
Stefan Mergler,
Heike Biebermann
Publication year - 2015
Publication title -
european thyroid journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.23
H-Index - 10
eISSN - 2235-0802
pISSN - 2235-0640
DOI - 10.1159/000381801
Subject(s) - medicine , receptor , signal transduction , ligand (biochemistry) , β2 adrenergic receptor , microbiology and biotechnology , adrenergic receptor , pharmacology , endocrinology , agonist , biology
3-Iodothyronamine (3-T1AM), a signaling molecule with structural similarities to thyroid hormones, induces numerous physiological responses including reversible body temperature decline. One target of 3-T1AM is the trace amine-associated receptor 1 (TAAR1), which is a member of the rhodopsin-like family of G protein-coupled receptors (GPCRs). Interestingly, the effects of 3-T1AM remain detectable in TAAR1 knockout mice, suggesting further targets for 3-T1AM such as adrenergic receptors. Therefore, we evaluated whether β-adrenergic receptor 1 (ADRB1) and 2 (ADRB2) signaling is affected by 3-T1AM in HEK293 cells and in human conjunctival epithelial cells (IOBA-NHC), where these receptors are highly expressed endogenously.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom